Global Infection Control Market by Product Type (Disinfectants Products, Sterilization Services, Consumables, Personal Protective Equipment, Others), End-user (Hospital, Pharmaceutical laboratories, Clinical Laboratories, Medical device companies, Others) - Forecast to 2029

6.7%
CAGR (2024-2030)
49.08 USD Bn.
Market Size
305
Report Pages
137
Market Tables

Overview

The Infection Control Market size was valued at USD 49.08 Billion in 2023 and the total Infection Control Market revenue is expected to grow at a CAGR of 6.7 % from 2024 to 2030, reaching nearly USD 72.43 Billion.

Infection Control Market Overview

The increasing demands for infection Control across industries are being met by Sterilization equipment innovations that improve the efficiency and effectiveness of sterilizing operations, increase hygiene awareness, increase healthcare-associated infections, and weaken immune systems. Businesses now access more advanced solutions because of technological advancements, which are expanding their Infection Control Market and raising infection control standards globally, which have a huge positive impact on the infection control market.

Infection Control MarketTo know about the Research Methodology :- Request Free Sample Report

The infection control market is expected to grow significantly. New trends such as evolving glove technology, rising healthcare expenditures, and growth in developing economies present that give a positive image. The Infection Control Market is growing subjected to environmentally friendly substitutes, customizing gloves to meet particular medical requirements, and utilizing digital technology for compliance tracking and training. Potential solutions are provided by technological innovations such as automation, artificial intelligence (AI) in disinfection robots, and antimicrobial surfaces based on nanotechnology. Reusable personal protective equipment (PPE) and environmentally friendly disinfectants are becoming more popular as sustainability gains drivers.

Infection Control Market Dynamics

The number of surgical procedures practices has significantly risen in recent years: Infection Control Market demand is high Due to several variables, such as the increasing rate of obesity, population aging, lifestyle disorders, sports, and spinal-related injuries. As a result, the market for surgical instruments and medical devices is growing. This increase highlights the significance of infection control services and solutions, which are motivated by their acknowledged advantages and growing recognition of their efficacy in hospital environments. To avoid healthcare-associated infections, surgical site infections and, it is important to maintain proper infection control as surgical treatments are becoming common now. As per the 2023 NCBI, there was a significant rise in cosmetic treatments in 2021 as compared to the prior years. This increase in surgical procedures highlights the growing demand for infection control measures, which is expected to propel infection control technology adoption the during forecasted period and drive the Infection Control Market growth.

Infection Control Market

High Expenses for Surgery and Treatments and Restrains: High costs associated with treatment and surgeries are significant obstacles to the Infection Control market. Like endoscopy incurs higher costs for the purchase of equipment, maintenance, and cleaning services that are burdens for many healthcare facilities in resource planning. The huge cost of endoscopic reprocessing and the low compensation in poor countries are major barriers to the growth of the infection control market. The growth of the market is expected to be controlled by concerns about the quality of reprocessed instruments and the side effects of chemical disinfectants. The increased use of single-use medical polymeric and devices is expected to present profitable opportunities during the forecasted period.

Infection Control Market Segment Analysis

By Type: The Global Infection Control Market is dominated by the consumables sector. These include preventive like disinfectants and sterilization items that comprise the consumables segment's subsegments. The frequent usage of face masks, sponges, and hand sanitizer is significantly raising this segment and resulting in the growth of the Infection control market. For example, according to a UNICEF article, 134 countries received 385 million surgical and 23.3 million N95 respiratory masks from UNICEF. In 2020, Taiwan also sent 10 million masks to the United States and Europe. Because these products are used frequently and have a limited shelf life, such donations have increased the market share of the consumables segment in previous years and are predicted to do so in the years to come.

Infection Control Market

Based on End-Use: The market is segmented into Hospitals, Pharmaceutical companies, Medical device companies, clinical laboratories, and others. The Hospital Sector dominated the infection control market with a 39.5% revenue share in 2022 and is expected to rise at the highest rate during the forecast period. The substantial growth is mostly caused by the high risk of infection on hospital grounds from bloodborne or respiratory pathogens. One of the main issues is HAIs, which necessitates stringent management. This has forced hospitals and public health agencies to put in place extremely efficient control systems. Furthermore, an estimated 40–60% of hospital infections are believed to have their origins in surgical sites, according to studies published in NCBI.

Based on Regional Analysis, North America is dominating the Infection control market with a xx% market share in 2023. Due to good collaborations and partnerships by key players in the market to increase their product portfolio and infection control capabilities across the region. North America has good infrastructure and strict regulations, this region gives preference to infection prevention and drives the demand for sterilization products and services. One of the main factors for the growth of North America is the rise in healthcare expenditure. Therefore, the need for infection control products in North America has been increased further by the rise in infectious diseases as well as increased awareness about personal hygiene and testing for urinary tract infections that leading industry players with a focus on product developments, such as Cardinal Health, 3M and others, are also located in North America and contributing to the growth of the sector.

In Asia Pacific the infection control market is expected to grow at the fastest CAGR due to the advancements in healthcare infrastructure and standards, also outsourcing companies, and rising healthcare expenses are growing in numbers. A major driver of the Asia-Pacific region's growth is the increase in due to improving infection control practices by governments and Companies. One of the main factors driving the market growth is that Developed economies are outsourcing to companies in the Asia-Pacific Region. Because of the low cost of production and excess availability of manpower. For example, the Asia Pacific Society of Infection Control (APSIC) conducts infection control research and forms cooperative collaborations to support quality improvement to promote cost-effective techniques in the Asia Pacific area.

The report aims to provide industry stakeholders with a thorough study of the global Infection Control market. The research presents the industry's historical and present state together with projected market size and trends, analyzing complex data in an easy-to-read manner. The study includes a thorough analysis of important competitors, including market leaders, followers, and recent entrants, and it covers every facet of the industry.

The research includes PORTER and PESTEL analyses along with the possible effects of market microeconomic factors. The analysis of both internal and external elements that could have a good or negative impact on the firm will provide decision-makers with a clear picture of the industry's future.

By understanding the market segments and projecting the size of the global market, the reports also help in understanding the market's dynamics and structure. The study serves as an investor's guide and gives a clear representation of the competitive analysis of key companies in the global Market by product, price, financial situation, product portfolio, growth plans, and regional presence.

Infection Control Industry Ecosystem Infection Control Industry Ecosystem

Infection Control Market Scope: Inquire before buying

Global Infection Control Market
Report Coverage Details
Base Year: 2023 Forecast Period: 2024-2030
Historical Data: 2018 to 2023 Market Size in 2023: US $ 49.08 Bn.
Forecast Period 2024 to 2030 CAGR: 6.7% Market Size in 2030: US $ 72.43 Bn.
Segments Covered: by Product Type Disinfectants Products
Sterilization Services
Consumables
Personal Protective Equipment
Others
by End-user Hospital
Pharmaceutical laboratories
Clinical Laboratories
Medical device companies
Others

Infection Control Market, by Region:

North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina Rest of South America)

Infection Control Market, Key Players

1. 3D Systems (US)
2. Melag Medizintechnik OHG
3. Belimed AG
4. Matachana
5. 3M
6. The Miele Group
7. Getinge
8. Steris
9. Cantel Medical
10. Advanced Sterilization Products
11. MMM Group
12. Sotera Health LLC
13. Reckitt Benckiser
14. Pal International
15. Halyard Health
16. Ecolab
17. Stryker Corporation
18. Cardinal Health
19. Paul Hartmann AG
20. Belimed AG
21. Matachana Group
22. Medline Industries, Inc.
23. Ansell Healthcare
24. Tso3 Inc.
25. Others

Frequently Asked Questions:

1] What segments are covered in the Global Market report?
Ans. The segments covered in the Infection Control Market report are offers on Product Type, End-Use Industry, and Region.

2] What is the expected CAGR of the Global Infection Control Market during the forecast period?
Ans. The expected CAGR of the Infection Control Market is 6.7% during the forecast period

3] What is the expected Infection Control Market size by 2030?
Ans. The Infection Control Market size is expected to reach US$ 72.43 Bn by 2030.

4] Which region held the largest Infection Control Market share in 2023?
Ans. The North American region held the largest Infection Control Market share in 2023

5] What were the key players in the Global Infection Control Market?
Ans. 3M, Getinge, Metrex, Steris, The Miele Group, and MMM Group, are the top key players in the Global Cloud Security

Table of Contents

1. Infection Control Introduction 1.1. Study Assumption and Market Definition 1.2. Scope of the Study 2. Global Infection Control: Competitive Landscape 2.1. MMR Competition Matrix 2.2. Competitive Landscape 2.3. Market share analysis of major players 2.4. Products specific analysis 2.5. Key Players Benchmarking 2.5.1. Company Name 2.5.2. Product Segment 2.5.3. End-user Segment 2.5.4. Revenue (2023) 2.5.5. Key Development 2.5.6. Market Share 2.6. Industry Ecosystem 2.6.1. Key players in the Infection Control ecosystem 2.6.2. Role of companies in the Infection Control ecosystem 2.7. Market Structure 2.7.1. Market Leaders 2.7.2. Market Followers 2.7.3. Emerging Players 2.8. Consolidation of the Market 2.8.1. Strategic Initiatives and Developments 2.8.2. Mergers and Acquisitions 2.8.3. Collaborations and Partnerships 2.8.4. Product Launches and Innovations 3. Infection Control: Dynamics 3.1. Infection Control Trends by Region 3.1.1. North America Infection Control Trends 3.1.2. Europe Infection Control Trends 3.1.3. Asia Pacific Infection Control Trends 3.1.4. South America Infection Control Trends 3.1.5. Middle East & Africa (MEA) Infection Control Trends 3.2. Infection Control Dynamics by Region 3.2.1. Drivers 3.2.2. Restraints 3.2.3. Opportunities 3.2.4. Challenges 3.3. PORTER’s Five Forces Analysis 3.3.1. Threat of New Entrants 3.3.2. Threat of Substitutes 3.3.3. Bargaining Power of Suppliers 3.3.4. Bargaining Power of Buyers 3.3.5. Intensity of Competitive Rivalry 3.4. Impact of Trends and Disruption on Manufacturer 3.5. Technological Analysis 3.5.1. Supercritical CO2 Technology 3.5.2. Ultra-high-pressure sterilization 3.5.3. Plasma sterilization 3.6. AI in infection control tools like sterilization equipment 3.7. Key Stakeholder and Buying Criteria 3.7.1. Influence of Stakeholders on the Buying Process for the Top Applications 3.7.2. Key Buying Criteria for Top Applications 3.8. Regulatory Landscape 3.8.1. Regulation by Region 3.8.2. Tariff and Taxes 3.8.3. Regulatory Bodies, Government agencies, and other organizations by Region 4. Infection Control: Global Market Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 4.1. Global Infection Control Size and Forecast, by Product Type (2023-2030) 4.1.1. Disinfectants Products 4.1.2. Sterilization Services 4.1.3. Consumables 4.1.4. Personal Protective Equipment 4.1.5. Others 4.2. Global Infection Control Size and Forecast, by End User (2023-2030) 4.2.1. Hospital 4.2.2. Pharmaceutical laboratories 4.2.3. Clinical Laboratories 4.2.4. Medical device companies 4.2.5. Others 4.3. Global Infection Control Size and Forecast, by Region (2023-2030) 4.3.1. North America 4.3.2. Europe 4.3.3. Asia Pacific 4.3.4. South America 4.3.5. MEA 5. North America Infection Control Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 5.1. North America Infection Control Size and Forecast, by Product Type (2023-2030) 5.1.1. Disinfectants Products 5.1.2. Sterilization Services 5.1.3. Consumables 5.1.4. Personal Protective Equipment 5.1.5. Others 5.2. North America Infection Control Size and Forecast, by End User (2023-2030) 5.2.1. Hospital 5.2.2. Pharmaceutical laboratories 5.2.3. Clinical Laboratories 5.2.4. Medical device companies 5.2.5. Others 5.3. North America Infection Control Size and Forecast, by Country (2023-2030) 5.3.1. United States 5.3.1.1. United States Infection Control Size and Forecast, by Product Type (2023-2030) 5.3.1.1.1. Disinfectants Products 5.3.1.1.2. Sterilization Services 5.3.1.1.3. Consumables 5.3.1.1.4. Personal Protective Equipment 5.3.1.1.5. Others 5.3.1.2. United States Infection Control Size and Forecast, by End User (2023-2030) 5.3.1.2.1. Hospital 5.3.1.2.2. Pharmaceutical laboratories 5.3.1.2.3. Clinical Laboratories 5.3.1.2.4. Medical device companies 5.3.1.2.5. Others 5.3.2. Canada 5.3.2.1. Canada Infection Control Size and Forecast, by Product Type (2023-2030) 5.3.2.1.1. Disinfectants Products 5.3.2.1.2. Sterilization Services 5.3.2.1.3. Consumables 5.3.2.1.4. Personal Protective Equipment 5.3.2.1.5. Others 5.3.2.2. Canada Infection Control Size and Forecast, by End User (2023-2030) 5.3.2.2.1. Hospital 5.3.2.2.2. Pharmaceutical laboratories 5.3.2.2.3. Clinical Laboratories 5.3.2.2.4. Medical device companies 5.3.2.2.5. Others 5.3.3. Mexico 5.3.3.1. Mexico Infection Control Size and Forecast, by Product Type (2023-2030) 5.3.3.1.1. Disinfectants Products 5.3.3.1.2. Sterilization Services 5.3.3.1.3. Consumables 5.3.3.1.4. Personal Protective Equipment 5.3.3.1.5. Others 5.3.3.2. Mexico Infection Control Size and Forecast, by End User (2023-2030) 5.3.3.2.1. Hospital 5.3.3.2.2. Pharmaceutical laboratories 5.3.3.2.3. Clinical Laboratories 5.3.3.2.4. Medical device companies 5.3.3.2.5. Others 6. Europe Infection Control Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 6.1. Europe Infection Control Size and Forecast, by Product Type (2023-2030) 6.2. Europe Infection Control Size and Forecast, by End User (2023-2030) 6.3. Europe Infection Control Size and Forecast, by Country (2023-2030) 6.3.1. United Kingdom 6.3.1.1. United Kingdom Infection Control Size and Forecast, by Product (2023-2030) 6.3.1.2. United Kingdom Infection Control Size and Forecast, by End User (2023-2030) 6.3.2. France 6.3.2.1. France Infection Control Size and Forecast, by Product Type (2023-2030) 6.3.2.2. France Infection Control Size and Forecast, by End User (2023-2030) 6.3.3. Germany 6.3.3.1. Germany Infection Control Size and Forecast, by Product Type (2023-2030) 6.3.3.2. Germany Infection Control Size and Forecast, by End User (2023-2030) 6.3.4. Italy 6.3.4.1. Italy Infection Control Size and Forecast, by Product Type (2023-2030) 6.3.4.2. Italy Infection Control Size and Forecast, by End User (2023-2030) 6.3.5. Spain 6.3.5.1. Spain Infection Control Size and Forecast, by Product Type (2023-2030) 6.3.5.2. Spain Infection Control Size and Forecast, by End User (2023-2030) 6.3.6. Sweden 6.3.6.1. Sweden Infection Control Size and Forecast, by Product Type (2023-2030) 6.3.6.2. Sweden Infection Control Size and Forecast, by End User (2023-2030) 6.3.7. Austria 6.3.7.1. Austria Infection Control Size and Forecast, by Product Type (2023-2030) 6.3.7.2. Austria Infection Control Size and Forecast, by End User (2023-2030) 6.3.8. Rest of Europe 6.3.8.1. Rest of Europe Infection Control Size and Forecast, by Product Type (2023-2030) 6.3.8.2. Rest of Europe Infection Control Size and Forecast, by End User (2023-2030) 7. Asia Pacific Infection Control Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 7.1. Asia Pacific Infection Control Size and Forecast, by Product Type (2023-2030) 7.2. Asia Pacific Infection Control Size and Forecast, by End User (2023-2030) 7.3. Asia Pacific Infection Control Size and Forecast, by Country (2023-2030) 7.3.1. China 7.3.1.1. China Infection Control Size and Forecast, by Product Type (2023-2030) 7.3.1.2. China Infection Control Size and Forecast, by End User (2023-2030) 7.3.2. S Korea 7.3.2.1. S Korea Infection Control Size and Forecast, by Product Type (2023-2030) 7.3.2.2. S Korea Infection Control Size and Forecast, by End User (2023-2030) 7.3.3. Japan 7.3.3.1. Japan Infection Control Size and Forecast, by Product Type (2023-2030) 7.3.3.2. Japan Infection Control Size and Forecast, by End User (2023-2030) 7.3.4. India 7.3.4.1. India Infection Control Size and Forecast, by Product Type (2023-2030) 7.3.4.2. India Infection Control Size and Forecast, by End User (2023-2030) 7.3.5. Australia 7.3.5.1. Australia Infection Control Size and Forecast, by Product Type (2023-2030) 7.3.5.2. Australia Infection Control Size and Forecast, by End User (2023-2030) 7.3.6. ASEAN 7.3.6.1. ASEAN Infection Control Size and Forecast, by Product Type (2023-2030) 7.3.6.2. ASEAN Infection Control Size and Forecast, by End User (2023-2030) 7.3.7. Rest of Asia Pacific 7.3.7.1. Rest of Asia Pacific Infection Control Size and Forecast, by Product Type (2023-2030) 7.3.7.2. Rest of Asia Pacific Infection Control Size and Forecast, by End User (2023-2030) 8. South America Infection Control Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 8.1. South America Infection Control Size and Forecast, by Product Type (2023-2030) 8.2. South America Infection Control Size and Forecast, by End User (2023-2030) 8.3. South America Infection Control Size and Forecast, by Country (2023-2030) 8.3.1. Brazil 8.3.1.1. Brazil Infection Control Size and Forecast, by Product Type (2023-2030) 8.3.1.2. Brazil Infection Control Size and Forecast, by End User (2023-2030) 8.3.2. Argentina 8.3.2.1. Argentina Infection Control Size and Forecast, by Product Type (2023-2030) 8.3.2.2. 8.3.2.3. Argentina Infection Control Size and Forecast, by End User (2023-2030) 8.3.3. Rest Of South America 8.3.3.1. Rest Of South America Infection Control Size and Forecast, by Product Type (2023-2030) 8.3.3.2. Rest Of South America Infection Control Size and Forecast, by End User (2023-2030) 9. Middle East and Africa Infection Control Size and Forecast by Segmentation (by Value USD Bn) (2023-2030) 9.1. Middle East and Africa Infection Control Size and Forecast, by Product Type (2023-2030) 9.2. Middle East and Africa Infection Control Size and Forecast, by End User (2023-2030) 9.3. Middle East and Africa Infection Control Size and Forecast, by Country (2023-2030) 9.3.1. South Africa 9.3.1.1. South Africa Infection Control Size and Forecast, by Product Type (2023-2030) 9.3.1.2. South Africa Infection Control Size and Forecast, by End User (2023-2030) 9.3.2. GCC 9.3.2.1. GCC Infection Control Size and Forecast, by Product Type (2023-2030) 9.3.2.2. GCC Infection Control Size and Forecast, by End User (2023-2030) 9.3.3. Rest Of MEA 9.3.3.1. Rest Of MEA Infection Control Size and Forecast, by Product Type (2023-2030) 9.3.3.2. Rest Of MEA Infection Control Size and Forecast, by End User (2023-2030) 10. Company Profile: Key Players 10.1. Metrex 10.1.1. Company Overview 10.1.2. Business Portfolio 10.1.3. Financial Overview 10.1.4. SWOT Analysis (Technological strengths and weaknesses) 10.1.5. Strategic Analysis (Recent strategic moves) 10.1.6. Recent Developments 10.2. Melag Medizintechnik OHG 10.3. Belimed AG 10.4. Matachana 10.5. 3M 10.6. The Miele Group 10.7. Getinge 10.8. Steris 10.9. Cantel Medical 10.10. Advanced Sterilization Products 10.11. MMM Group 10.12. Sotera Health LLC 10.13. Reckitt Benckiser 10.14. Pal International 10.15. Halyard Health 10.16. Ecolab 10.17. Stryker Corporation 10.18. Cardinal Health 10.19. Paul Hartmann AG 10.20. Belimed AG 10.21. Matachana Group 10.22. Medline Industries, Inc. 10.23. Ansell Healthcare 10.24. Tso3 Inc. 10.25. Others 11. Key Findings and Analyst Recommendations 11.1. Attractive Opportunities for Players in the Infection Control 12. Infection Control: Research Methodology 12.1. Market Size Estimation 12.1.1. Bottom-Up Approach 12.1.2. Top-Down Approach 12.2. Market Breakdown and Data Triangulation